Endo International Ordinary Shares reported $-3925041000 in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Amarin AMRN:US USD 587.83M 7.78M
Ani Pharmaceuticals ANIP:US USD 338.54M 1.86M
Coherus Biosciences CHRS:US USD -137418000 40.28M
Endo International Ordinary Shares ENDP:US USD -3925041000 726.97M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Hikma Pharmaceutical HIK:LN USD 2.14B 41M
Horizon Pharma HZNP:US USD 5.07B 38.49M
Lannett LCI:US USD -312274000 34.71M
Ligand Pharmaceuticals LGND:US USD 597.48M 218.81M
Novartis NOVN:VX USD 59.34B 1.48B
Pacira Pharmaceuticals PCRX:US USD 775.01M 4.89M
Patterson Companies PDCO:US USD 1.1B 60.4M
Perrigo Ordinary Shares PRGO:US USD 4.84B 239.4M
Phibro Animal Health PAHC:US USD 268.37M 5.61M
Revance Therapeutics RVNC:US USD 12.6M 133.11M
Supernus Pharmaceuticals SUPN:US USD 886.2M 33.41M
Takeda 4502:JP JPY 6.18T 536.95B
Teva Pharmaceutical TEVA:IT USD 7.9B 871M
Xeris Pharmaceuticals Inc XERS:US USD 45.19M 9.85M
Zoetis ZTS:US USD 4.4B 258M